Autres langues LanZhou Foci Pharmaceutical Co.,Ltd.

Actions

002644

CNE1000019W4

Produits pharmaceutiques

Cours en clôture Shenzhen S.E. 30/09/2026			Varia. 5j.	Varia. 1 janv.
8,260 ^CNY	+0,98%		+1,10%	-4,40%

09/09	Lanzhou Foci Pharmaceutical Co.,Ltd. approuve son plan de distribution des bénéfices pour le premier semestre 2026	CI
20/08	Lanzhou Foci Pharmaceutical Co.,Ltd. propose un plan de distribution de bénéfices pour le premier semestre 2026	CI

Autres langues

09/09	Lanzhou Foci Pharmaceutical Co.,Ltd. Approves 2026 Interim Profit Distribution Plan
20/08	Lanzhou Foci Pharmaceutical Co.,Ltd. Proposes 2026 Interim Profit Distribution Plan
19/08	LanZhou Foci Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026
11/05	LanZhou Foci Pharmaceutical Co.,Ltd. Approves Cash Dividend for the Year 2025
29/04	LanZhou Foci Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026
08/04	LanZhou Foci Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025
08/04	LanZhou Foci Pharmaceutical Co.,Ltd. announces Annual dividend, payable on June 26, 2026
08/04	LanZhou Foci Pharmaceutical Co.,Ltd. announced that it expects to receive CNY 300 million in funding
28/10/25	LanZhou Foci Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025
10/10/25	Kejin Taiji New Technology Co., Ltd. announced that it expects to receive CNY 372.53 million in funding from a group of investors
26/08/25	LanZhou Foci Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025
23/05/25	Lanzhou Foci Pharmaceutical Co.,Ltd. Approves Final Cash Dividend on A Shares for the Year 2024, Payable on 24 June 2025
28/04/25	LanZhou Foci Pharmaceutical Co.,Ltd. Proposes Final Cash Dividend for the Year 2024
25/04/25	LanZhou Foci Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025
25/04/25	LanZhou Foci Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024
23/12/24	LanZhou Foci Pharmaceutical Co.,Ltd.(XSEC:002644) dropped from S&P Global BMI Index
25/10/24	LanZhou Foci Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024
26/08/24	LanZhou Foci Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024
15/08/24	LanZhou Foci Pharmaceutical Co.,Ltd. Announces Board Appointments
18/06/24	LanZhou Foci Pharmaceutical Co.,Ltd. Announces Final Profit Distribution Plan on A Shares for the Year 2023, Payable on 25 June 2024
06/05/24	Lanzhou Foci Pharmaceutical Co.,Ltd. Approves Final Cash Dividend for the Year 2023
10/04/24	Lanzhou Foci Pharmaceutical Chairman Resigns
10/04/24	Lanzhou Foci Pharmaceutical Co.,Ltd. Proposes Final Cash Dividend for the Year 2023
09/04/24	LanZhou Foci Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
09/04/24	LanZhou Foci Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023